N. Grañé-Boladeras

Pharmacogenomic analyzis of the responsiveness of gastrointestinal tumor cell lines to drug therapy: A transportome approach.

A. Mazo, S. Pérez-Torras, J. Lozano, 2016, Pharmacological research.

Oligomerization of equilibrative nucleoside transporters: a novel regulatory and functional mechanism involving PKC and PP1

P. Mehrabi, M. Pastor-Anglada, I. Coe, 2018, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

Up-regulation of FXR isoforms is not required for stimulation of the expression of genes involved in the lack of response of colon cancer to chemotherapy.

J. Marin, R. Macias, M. Pastor-Anglada, 2012, Pharmacological research.

Novel nuclear hENT2 isoforms regulate cell cycle progression via controlling nucleoside transport and nuclear reservoir

M. Pastor-Anglada, I. Coe, C. Spring, 2016, Cellular and Molecular Life Sciences.

No correlation between the expression of FXR and genes involved in multidrug resistance phenotype of primary liver tumors.

M. Serrano, B. Sangro, J. Marin, 2012, Molecular pharmaceutics.

Nucleoside transporters in the purinome

I. Coe, N. Grañé-Boladeras, Alexandre dos Santos-Rodrigues, 2014, Neurochemistry International.

No correlation between the expression of FXR and genes involved in multidrug resistance phenotype of primary liver tumors.

M. Serrano, B. Sangro, J. Marin, 2012, Molecular pharmaceutics.